Ekso Bionics Investor Relations Material
Latest events
Q4 2023
Ekso Bionics
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Ekso Bionics Holdings Inc
Access all reports
Ekso Bionics Holdings designs, develops, sells and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, Asia Pacific and internationally. The company operates in two segments: EksoHealth and EksoWorks. The former designs, engineers, manufactures and markets exoskeletons for applications in various industries, including medical as well as industrial, construction and military segments. EksoWorks focuses on creating exoskeleton devices allowing able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR - a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke or spinal cord injury; as well as EksoUE - a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. The company has license agreements with Lockheed Martin Corporation under which it can use certain intellectual property developed by Lockheed Martin for military exoskeletons
Key slides for Ekso Bionics Holdings Inc
Investor Presentation
Ekso Bionics Holdings Inc
Investor Presentation
Ekso Bionics Holdings Inc
Latest articles
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Ticker symbol
Country
🇺🇸 United States